ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 62 filers reported holding ALLOVIR INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $121,185 | -44.2% | 56,365 | -11.7% | 0.00% | – |
| Q2 2023 | $217,066 | +5.2% | 63,843 | +21.9% | 0.00% | – |
| Q1 2023 | $206,432 | -23.8% | 52,394 | -0.8% | 0.00% | – |
| Q4 2022 | $270,869 | -34.3% | 52,801 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $412,000 | +162.4% | 52,217 | +29.6% | 0.00% | – |
| Q2 2022 | $157,000 | -46.0% | 40,293 | -6.5% | 0.00% | – |
| Q1 2022 | $291,000 | -51.4% | 43,095 | -6.9% | 0.00% | -100.0% |
| Q4 2021 | $599,000 | -47.3% | 46,313 | +2.1% | 0.00% | 0.0% |
| Q3 2021 | $1,136,000 | +41.5% | 45,343 | +11.5% | 0.00% | 0.0% |
| Q2 2021 | $803,000 | -23.2% | 40,671 | -8.9% | 0.00% | 0.0% |
| Q1 2021 | $1,045,000 | +0.2% | 44,652 | +64.6% | 0.00% | 0.0% |
| Q4 2020 | $1,043,000 | +39.8% | 27,125 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $746,000 | – | 27,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |